Arman Oruc joined the Bloomberg Intelligence podcast to share his views on the FTC, and its impact on M&A for the pharma and biotech industry.
Listen to the podcast here.
The post Bloomberg Intelligence – Arman Oruc's Perspective on the FTC and Pharma and Biotech Industry M&A Impact appeared first on Life Sciences Perspectives.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.